Pliant Therapeutics, Inc. · NASDAQ:PLRX
Morgan Stanley's stake in Pliant Therapeutics, Inc. fell to 0.90% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 8, 2026
Morgan Stanley's stake in Pliant Therapeutics, Inc. fell to 0.90%, 545,228 shares, as a passive investor on Dec 31, 2025. Filed Jan 8, 2026 (Schedule 13G/A).
- Stake
- 0.90%
- Shares
- 545,228
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 0.90% | 545,228 |
Source
Related
- Pliant Therapeutics, Inc.
- Morgan Stanley
- Pliant Therapeutics, Inc. shareholders
- Schedule 13G · Morgan Stanley · Aug 6, 2025
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Woodline Partners LP · Feb 17, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Feb 17, 2026
- Schedule 13G · Citadel Advisors LLC · Feb 9, 2026